Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial results report efficacy and safety of eslicarbazepine acetate for postherpetic neuralgia, with the study completed and results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED | Results posted: 2013-05-03